T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.1% |
| 2 | Technology | 17.78% |
| 3 | Consumer Discretionary | 15.32% |
| 4 | Financials | 14.61% |
| 5 | Industrials | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Duluth Holdings
DLTH
$151M
| $33.9M | ﹤0.01% |
1,077,901
+45
| +0% | +$1.23K |
|
|
ADSW
1052
DELISTED
Advanced Disposal Services Inc
ADSW
| $33.6M | ﹤0.01% |
1,239,078
+321,998
| +35% | +$8.26M |
|
1053
Essent Group
ESNT
$6.14B
| $33.5M | ﹤0.01% |
756,388
+9,270
| +1% | +$380K |
|
|
AZUL
1054
DELISTED
Azul
AZUL
| $33.5M | ﹤0.01% |
1,880,242
-21,700
| -1% | -$384K |
|
1055
Jazz Pharmaceuticals
JAZZ
$16B
| $33.2M | ﹤0.01% |
197,224
-227,469
| -54% | -$39.1M |
|
1056
RenaissanceRe
RNR
$13.2B
| $33M | ﹤0.01% |
246,866
-3,615
| -1% | -$467K |
|
1057
Best Buy
BBY
$18B
| $33M | ﹤0.01% |
415,333
+5,215
| +1% | +$404K |
|
|
MRO
1058
DELISTED
Marathon Oil Corporation
MRO
| $32.9M | ﹤0.01% |
1,411,117
+3,840
| +0.3% | +$80.4K |
|
1059
Huron Consulting
HURN
$2.47B
| $32.8M | ﹤0.01% |
+664,789
| New | +$31.1M |
|
1060
Brown-Forman Class B
BF.B
$12.8B
| $32.6M | ﹤0.01% |
645,736
-127,654
| -17% | -$6.63M |
|
|
BEAT
1061
DELISTED
BioTelemetry, Inc.
BEAT
| $32.6M | ﹤0.01% |
506,152
+10,607
| +2% | +$592K |
|
1062
Citizens Financial Group
CFG
$31.1B
| $32.6M | ﹤0.01% |
844,700
-54,455
| -6% | -$2.2M |
|
|
RETA
1063
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $32.5M | ﹤0.01% |
+397,279
| New | +$28M |
|
1064
Hartford Financial Services
HIG
$37.7B
| $32.4M | ﹤0.01% |
649,178
+1,378
| +0.2% | +$70.8K |
|
|
PARA
1065
DELISTED
Paramount Global Class B
PARA
| $32.4M | ﹤0.01% |
563,651
-37,073
| -6% | -$2.05M |
|
1066
Monolithic Power Systems
MPWR
$67B
| $32.3M | ﹤0.01% |
256,960
-30,479
| -11% | -$4.25M |
|
1067
A.O. Smith
AOS
$8.51B
| $32.1M | ﹤0.01% |
601,441
-26,701
| -4% | -$1.57M |
|
1068
Lantheus
LNTH
$6.57B
| $32M | ﹤0.01% |
2,138,589
-510,766
| -19% | -$7.46M |
|
1069
Cooper-Standard Automotive
CPS
$484M
| $31.9M | ﹤0.01% |
266,043
-687
| -0.3% | -$92.1K |
|
1070
Unifirst Corp
UNF
$5.24B
| $31.9M | ﹤0.01% |
183,552
+178,624
| +3,625% | +$32.9M |
|
1071
Quanex
NX
$1B
| $31.8M | ﹤0.01% |
1,746,455
-233,351
| -12% | -$4.11M |
|
1072
Ziff Davis
ZD
$1.92B
| $31.7M | ﹤0.01% |
439,657
+10,357
| +2% | +$758K |
|
|
REVG
1073
DELISTED
REV Group
REVG
| $31.6M | ﹤0.01% |
2,013,158
+448,325
| +29% | +$7.32M |
|
1074
FRP Holdings
FRPH
$425M
| $31.5M | ﹤0.01% |
1,014,880
+8,348
| +0.8% | +$268K |
|
1075
Fastenal
FAST
$59.9B
| $31.5M | ﹤0.01% |
2,170,060
-91,704
| -4% | -$1.31M |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.